Compaa Cerveceras Unidas S A, AstraZeneca PLC, Abbott Laboratories, Novartis AG, The Walt Disney Company, Yamana Gold, and Genpact Limited" name="Description" /> Compaa Cerveceras Unidas S A, AstraZeneca PLC, Abbott Laboratories, Novartis AG, The Walt Disney Company, Yamana Gold, and Genpact Limited" /> Compaa Cerveceras Unidas S A, AstraZeneca PLC, Abbott Laboratories, Novartis AG, The Walt Disney Company, Yamana Gold, and Genpact Limited" />

The Top 7 Compulsion stocks to own in August 2019

In this article I will break down 7 Compulsion isntruments to have in your portfolio in August 2019. I will cover Compaa Cerveceras Unidas S A, AstraZeneca PLC, Abbott Laboratories, Novartis AG, The Walt Disney Company, Yamana Gold, and Genpact Limited
Published over a year ago
View all stories for Macroaxis | View All Stories
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.

Reviewed by Michael Smolkin

This list of potential positions covers Addiction driven consumer products and services. Companies involved in research, development, and manufacturing of products with compulsion characteristics such as cigarettes, addictive drugs and alcohol in USA. Please note, we provide buy hold or sell recommendation only in the context of selected investment horizon assuming investor has average attitude towards taking risk. Please also consider using Portfolio Positions Ratings and Equity Ratings tools to further calibrate your research.
Story appears to be empty

Compania Cervecerias Unidas (CCU)

The company has Return on Asset of 0.0425 % which means that on every $100 spent on assets, it made $0.0425 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0854 %, implying that it generated $0.0854 on every 100 dollars invested. Compania Cervecerias' management efficiency ratios could be used to measure how well Compania Cervecerias manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Compania Cervecerias' Return On Capital Employed is comparatively stable compared to the past year. Return On Equity is likely to gain to 0.15 in 2024, whereas Return On Assets are likely to drop 0.03 in 2024. At this time, Compania Cervecerias' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 1.6 T in 2024, whereas Total Current Liabilities is likely to drop slightly above 363.6 B in 2024. This firm currently falls under 'Mid-Cap' category with a total capitalization of 2.21 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Compania Cervecerias's market, we take the total number of its shares issued and multiply it by Compania Cervecerias's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Compania Cervecerias shows a prevailing Real Value of $15.24 per share. The current price of the firm is $11.99. Our model approximates the value of Compania Cervecerias from analyzing the firm fundamentals such as Current Valuation of 2.9 B, return on equity of 0.0854, and Profit Margin of 0.04 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

AstraZeneca PLC ADR (AZN)

The company has Return on Asset of 0.066 % which means that on every $100 spent on assets, it made $0.066 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1564 %, implying that it generated $0.1564 on every 100 dollars invested. AstraZeneca PLC's management efficiency ratios could be used to measure how well AstraZeneca PLC manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of March 2024, Return On Assets is likely to grow to 0.10, while Return On Capital Employed is likely to drop 0.11. At this time, AstraZeneca PLC's Asset Turnover is very stable compared to the past year. The entity currently falls under 'Mega-Cap' category with a total capitalization of 210.7 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AstraZeneca PLC's market, we take the total number of its shares issued and multiply it by AstraZeneca PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

30.05 Billion

At this time, AstraZeneca PLC's Short and Long Term Debt Total is very stable compared to the past year.

Abbott Laboratories (ABT)

The company has Return on Asset of 0.0611 % which means that on every $100 spent on assets, it made $0.0611 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1511 %, implying that it generated $0.1511 on every 100 dollars invested. Abbott Laboratories' management efficiency ratios could be used to measure how well Abbott Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Abbott Laboratories' Return On Assets are comparatively stable compared to the past year. Return On Equity is likely to gain to 0.26 in 2024, whereas Return On Capital Employed is likely to drop 0.10 in 2024. At this time, Abbott Laboratories' Non Current Liabilities Other is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 44.7 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 8.3 B in 2024. The firm currently falls under 'Mega-Cap' category with a total capitalization of 196.91 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abbott Laboratories's market, we take the total number of its shares issued and multiply it by Abbott Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be fairly valued. Abbott Laboratories shows a prevailing Real Value of $114.32 per share. The current price of the firm is $113.66. Our model approximates the value of Abbott Laboratories from analyzing the firm fundamentals such as return on equity of 0.15, and Profit Margin of 0.14 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

Novartis AG ADR (NVS)

The company has Return on Asset of 0.0727 % which means that on every $100 spent on assets, it made $0.0727 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1615 %, implying that it generated $0.1615 on every 100 dollars invested. Novartis' management efficiency ratios could be used to measure how well Novartis manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Novartis' Return On Capital Employed is comparatively stable compared to the past year. Return On Equity is likely to gain to 0.33 in 2024, whereas Return On Assets are likely to drop 0.11 in 2024. At this time, Novartis' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 73.2 B in 2024, whereas Total Current Assets are likely to drop slightly above 29.9 B in 2024. The firm currently falls under 'Mega-Cap' category with a total capitalization of 198.19 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Novartis's market, we take the total number of its shares issued and multiply it by Novartis's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

18.64 Billion

At this time, Novartis' Short and Long Term Debt Total is comparatively stable compared to the past year.

Walt Disney (DIS)

The company has Return on Asset of 0.0322 % which means that on every $100 spent on assets, it made $0.0322 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.039 %, implying that it generated $0.039 on every 100 dollars invested. Disney's management efficiency ratios could be used to measure how well Disney manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to drop to 0.02 in 2024. Return On Assets is likely to drop to 0.01 in 2024. At this time, Disney's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 208.7 B in 2024, whereas Other Assets are likely to drop slightly above 10.5 B in 2024. The entity currently falls under 'Mega-Cap' category with a total capitalization of 221.91 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Disney's market, we take the total number of its shares issued and multiply it by Disney's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Walt Disney shows a prevailing Real Value of $134.63 per share. The current price of the firm is $122.36. Our model computes the value of Walt Disney from reviewing the firm fundamentals such as Return On Equity of 0.039, operating margin of 0.13 %, and Current Valuation of 262.41 B as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise acquiring undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will submerge.

Yamana Gold (AUY)

The company has Return on Asset of (0.1288) % which means that on every $100 spent on assets, it lost $0.1288. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.3137) %, meaning that it generated no profit with money invested by stockholders. Yamana Gold's management efficiency ratios could be used to measure how well Yamana Gold manages its routine affairs as well as how well it operates its assets and liabilities. This firm currently falls under 'Mid-Cap' category with a total capitalization of 5.63 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Yamana Gold's market, we take the total number of its shares issued and multiply it by Yamana Gold's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Genpact Limited (G)

The company has return on total asset of 0.083 % which means that for every 100 dollars spent on assets, it generated a profit of $0.083. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3099 %, implying that it made 0.3099 on every $100 invested by shareholders. Genpact's management efficiency ratios could be used to measure how well Genpact manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Genpact's Return On Assets are most likely to slightly decrease in the upcoming years. The Genpact's current Return On Equity is estimated to increase to 0.29, while Return On Capital Employed is projected to decrease to 0.1. At this time, Genpact's Other Current Assets are most likely to increase significantly in the upcoming years. The Genpact's current Return On Assets is estimated to increase to 0.14, while Total Assets are projected to decrease to roughly 3.1 B. The firm currently falls under 'Mid-Cap' category with a current capitalization of 5.91 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genpact's market, we take the total number of its shares issued and multiply it by Genpact's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Genpact Limited retains a regular Real Value of $38.11 per share. The prevalent price of the firm is $32.95. Our model calculates the value of Genpact Limited from evaluating the firm fundamentals such as Return On Equity of 0.31, current valuation of 6.83 B, and Return On Asset of 0.083 as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage locking in undervalued assets and disposing overvalued assets since, at some point, asset prices and their ongoing real values will come together.

Current Compulsion Recommendations


How important is Macroaxis's Liquidity

Macroaxis financial leverage refers to using borrowed capital as a funding source to finance Macroaxis ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Macroaxis financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Macroaxis' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Macroaxis' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Macroaxis's total debt and its cash.

Macroaxis Gross Profit

Macroaxis Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Macroaxis previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Macroaxis Gross Profit growth over the last 10 years. Please check Macroaxis' gross profit and other fundamental indicators for more details.
Story appears to be empty

Compania Cervecerias Unidas (CCU)

The company has Return on Asset of 0.0425 % which means that on every $100 spent on assets, it made $0.0425 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0854 %, implying that it generated $0.0854 on every 100 dollars invested. Compania Cervecerias' management efficiency ratios could be used to measure how well Compania Cervecerias manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Compania Cervecerias' Return On Capital Employed is comparatively stable compared to the past year. Return On Equity is likely to gain to 0.15 in 2024, whereas Return On Assets are likely to drop 0.03 in 2024. At this time, Compania Cervecerias' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 1.6 T in 2024, whereas Total Current Liabilities is likely to drop slightly above 363.6 B in 2024. This firm currently falls under 'Mid-Cap' category with a total capitalization of 2.21 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Compania Cervecerias's market, we take the total number of its shares issued and multiply it by Compania Cervecerias's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Compania Cervecerias shows a prevailing Real Value of $15.24 per share. The current price of the firm is $11.99. Our model approximates the value of Compania Cervecerias from analyzing the firm fundamentals such as Current Valuation of 2.9 B, return on equity of 0.0854, and Profit Margin of 0.04 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

AstraZeneca PLC ADR (AZN)

The company has Return on Asset of 0.066 % which means that on every $100 spent on assets, it made $0.066 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1564 %, implying that it generated $0.1564 on every 100 dollars invested. AstraZeneca PLC's management efficiency ratios could be used to measure how well AstraZeneca PLC manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of March 2024, Return On Assets is likely to grow to 0.10, while Return On Capital Employed is likely to drop 0.11. At this time, AstraZeneca PLC's Asset Turnover is very stable compared to the past year. The entity currently falls under 'Mega-Cap' category with a total capitalization of 210.7 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AstraZeneca PLC's market, we take the total number of its shares issued and multiply it by AstraZeneca PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

30.05 Billion

At this time, AstraZeneca PLC's Short and Long Term Debt Total is very stable compared to the past year.

Abbott Laboratories (ABT)

The company has Return on Asset of 0.0611 % which means that on every $100 spent on assets, it made $0.0611 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1511 %, implying that it generated $0.1511 on every 100 dollars invested. Abbott Laboratories' management efficiency ratios could be used to measure how well Abbott Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Abbott Laboratories' Return On Assets are comparatively stable compared to the past year. Return On Equity is likely to gain to 0.26 in 2024, whereas Return On Capital Employed is likely to drop 0.10 in 2024. At this time, Abbott Laboratories' Non Current Liabilities Other is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 44.7 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 8.3 B in 2024. The firm currently falls under 'Mega-Cap' category with a total capitalization of 196.91 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abbott Laboratories's market, we take the total number of its shares issued and multiply it by Abbott Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be fairly valued. Abbott Laboratories shows a prevailing Real Value of $114.32 per share. The current price of the firm is $113.66. Our model approximates the value of Abbott Laboratories from analyzing the firm fundamentals such as return on equity of 0.15, and Profit Margin of 0.14 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

Novartis AG ADR (NVS)

The company has Return on Asset of 0.0727 % which means that on every $100 spent on assets, it made $0.0727 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1615 %, implying that it generated $0.1615 on every 100 dollars invested. Novartis' management efficiency ratios could be used to measure how well Novartis manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Novartis' Return On Capital Employed is comparatively stable compared to the past year. Return On Equity is likely to gain to 0.33 in 2024, whereas Return On Assets are likely to drop 0.11 in 2024. At this time, Novartis' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 73.2 B in 2024, whereas Total Current Assets are likely to drop slightly above 29.9 B in 2024. The firm currently falls under 'Mega-Cap' category with a total capitalization of 198.19 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Novartis's market, we take the total number of its shares issued and multiply it by Novartis's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

18.64 Billion

At this time, Novartis' Short and Long Term Debt Total is comparatively stable compared to the past year.

Walt Disney (DIS)

The company has Return on Asset of 0.0322 % which means that on every $100 spent on assets, it made $0.0322 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.039 %, implying that it generated $0.039 on every 100 dollars invested. Disney's management efficiency ratios could be used to measure how well Disney manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to drop to 0.02 in 2024. Return On Assets is likely to drop to 0.01 in 2024. At this time, Disney's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 208.7 B in 2024, whereas Other Assets are likely to drop slightly above 10.5 B in 2024. The entity currently falls under 'Mega-Cap' category with a total capitalization of 221.91 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Disney's market, we take the total number of its shares issued and multiply it by Disney's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Walt Disney shows a prevailing Real Value of $134.63 per share. The current price of the firm is $122.36. Our model computes the value of Walt Disney from reviewing the firm fundamentals such as Return On Equity of 0.039, operating margin of 0.13 %, and Current Valuation of 262.41 B as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise acquiring undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will submerge.

Yamana Gold (AUY)

The company has Return on Asset of (0.1288) % which means that on every $100 spent on assets, it lost $0.1288. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.3137) %, meaning that it generated no profit with money invested by stockholders. Yamana Gold's management efficiency ratios could be used to measure how well Yamana Gold manages its routine affairs as well as how well it operates its assets and liabilities. This firm currently falls under 'Mid-Cap' category with a total capitalization of 5.63 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Yamana Gold's market, we take the total number of its shares issued and multiply it by Yamana Gold's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Genpact Limited (G)

The company has return on total asset of 0.083 % which means that for every 100 dollars spent on assets, it generated a profit of $0.083. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3099 %, implying that it made 0.3099 on every $100 invested by shareholders. Genpact's management efficiency ratios could be used to measure how well Genpact manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Genpact's Return On Assets are most likely to slightly decrease in the upcoming years. The Genpact's current Return On Equity is estimated to increase to 0.29, while Return On Capital Employed is projected to decrease to 0.1. At this time, Genpact's Other Current Assets are most likely to increase significantly in the upcoming years. The Genpact's current Return On Assets is estimated to increase to 0.14, while Total Assets are projected to decrease to roughly 3.1 B. The firm currently falls under 'Mid-Cap' category with a current capitalization of 5.91 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genpact's market, we take the total number of its shares issued and multiply it by Genpact's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Genpact Limited retains a regular Real Value of $38.11 per share. The prevalent price of the firm is $32.95. Our model calculates the value of Genpact Limited from evaluating the firm fundamentals such as Return On Equity of 0.31, current valuation of 6.83 B, and Return On Asset of 0.083 as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage locking in undervalued assets and disposing overvalued assets since, at some point, asset prices and their ongoing real values will come together.

Current Compulsion Recommendations

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com

Did you try this?

Run Options Analysis Now

   

Options Analysis

Analyze and evaluate options and option chains as a potential hedge for your portfolios
All  Next Launch Module
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any private could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Consideration for investing

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
CEOs Directory
Screen CEOs from public companies around the world
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments